| Literature DB >> 33026574 |
Patricia de Los Rios1, Chinyere Okoli2, Erika Castellanos3, Brent Allan4, Benjamin Young5, Garry Brough6, Marvelous Muchenje7, Anton Eremin8, Giulio Maria Corbelli9, Marta McBritton10, W David Hardy11, Nicolas Van de Velde2.
Abstract
To assess challenges with daily oral antiretroviral therapy (ART), we analyzed data for 2389 participants in the 2019 Positive Perspectives survey of people living with HIV in 25 countries. ART-related challenges reported included difficulty swallowing pills (33.1% [790/2389]); stress from daily dosing routine (33.3% [795/2389]); bad memories from daily intake of HIV medication (35.1%[839/2389]), and concern "that having to take pills every day means a greater chance of revealing my HIV status to others" (37.9% [906/2389]). Individuals who felt empowered by daily oral dosing ["taking my pill(s) every day reassures me that my HIV is being kept under control"] had 69% higher odds of optimal overall health (AOR 1.69, 95% CI 1.40-2.04). Conversely, odds of optimal overall health were lower among those who felt daily pill intake "limits my day-to-day life" (AOR 0.53, 95% CI 0.44-0.64). These findings show that there is need for increased flexibility of ART delivery to meet diverse patient needs.Entities:
Keywords: Antiretrovirals; Difficulty swallowing; Privacy; Quality of life; Stigma
Mesh:
Substances:
Year: 2020 PMID: 33026574 PMCID: PMC7936969 DOI: 10.1007/s10461-020-03055-1
Source DB: PubMed Journal: AIDS Behav ISSN: 1090-7165